Yuan Goessi: One Bleed Is One Too Many for a Lifetime of Haemophilia A
Yuan Goessi, Digital Marketing Intern at Roche, shared a post on LinkedIn:
“At the heart of every discussion about the future of haemophilia A is the recognition that redefining care goes beyond medicine – it is about looking at patients’ whole lives, protecting joint health, and easing the daily anxieties that families carry across generations.
At Roche, we believe that even one bleed is one too many, especially for a condition like haemophilia A that is for life.
We are profoundly grateful to the dedicated clinicians, researchers, and patient organisations who partner with us every day.
Together, we are raising the bar to turn scientific progress into a new reality.
Find out more about our efforts in haemophilia A on our website.”
Procees to the video attached to the post.
Stay updated with Hemostasis Today.
-
Aug 12, 2026, 08:16Chengyong Yang: Can Plasma Reveal Cell Specific Signals
-
Aug 12, 2026, 07:49Alan Dursun: Phnom Penh, Cambodia – Part 3 – Turning Partnership into Action
-
Aug 12, 2026, 06:55Alejandro González Veliz: A Good PCI is not Just about Opening the Artery
-
Aug 12, 2026, 06:39Abdulmalik Alnuqydan: Why Do We Transfuse RBCs Less Than 7 Days Old to Newborns?
-
Aug 12, 2026, 06:24Lucas Jae: How Mitochondria Sense Heme Scarcity to Regulate Heme and Globin Production
-
Aug 12, 2026, 06:09Luis Tam։ New CDC Global Health Security Funding Opportunities
-
Aug 12, 2026, 06:09Yan Leyfman: Curative Strategies and Precision Medicine in Sickle Cell Disease
-
Aug 12, 2026, 06:01Sophie He: Exploring Manufacturing Scalability and Cell Separation
-
Aug 12, 2026, 05:47Shehab Mohamed: Philadelphia Negative MPNs in AYA vs Older Adults in Qatar